IDO1 and neoplasm: Inhibition of IDO activity was then assessed by measuring the amount of kynurenine converted from tryptophan; AIMS(EPT) successfully reduced kynurenine formation in both BMDCs (Figure 5i) and 4T1 tumor cells (Figure 5j).